Читать книгу Recent Advances in Dialysis Therapy in Japan - Группа авторов - Страница 59

1Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993;44:1086–1090.

2Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO: Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003;64:603–609.

3Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, et al: Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005;45:1058–1066.

4Naganuma T, Takemoto Y, Nakatani T: Overviews of patients with chronic dialysis patients in Osaka, as of December 2016. J Osaka Society for Dialysis Therapy 2017;35:145–163.

5Charidimou A, Kakar P, Fox Z, Werring DJ: Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke 2013;44:995–1001.

6Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S: Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997;28:1932–1939.

7Ovbiagele B, Saver JL: Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis 2006;22:83–90.

8Bruno A, Rosenberg GA: The spectrum of lacunar infarction in the elderly. Clin Geriatr Med 1991;7:443–453.

9Fisher CM: Lacunar strokes and infarcts: a review. Neurology 1982;32:871–876.

10Offenbacher H, Fazekas F, Schmidt R, Koch M, Fazekas G, Kapeller P: MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996;17:573–578.

11Naganuma T, Takemoto Y, Shoji T, Shima H, Ishimura E, Okamura M, et al: Factors associated with cerebral white matter hyperintensities in haemodialysis patients. Nephrology (Carlton) 2012;17:561–568.

12Naganuma T, Takemoto Y, Yamasaki T, Shima H, Shoji T, Ishimura E, et al: Factors associated with silent cerebral microbleeds in hemodialysis patients. Clin Nephrol 2011;75:346–355.

13Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T, et al: Silent cerebral infarction in hemodialysis patients. Am J Nephrol 2003;23:86–90.

14Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF: Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 1998;29:913–917.

15Shinkawa A, Ueda K, Kiyohara Y, Kato I, Sueishi K, Tsuneyoshi M, et al: Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 1995;26:380–385.

16Sato M, Ogawa T, Sugimoto H, Otsuka K, Nitta K: Relation of carotid intima-media thickness and silent cerebral infarction to cardiovascular events and all-cause mortality in chronic hemodialysis patients. Intern Med 2012;51:2111–2117.

17Naganuma T, Uchida J, Tsuchida K, Takemoto Y, Tatsumi S, Sugimura K, et al: Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney Int 2005;67:2434–2439.

18Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274–1282.

19Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246–1252.

20Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, et al: Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262–2270.

21Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, et al: Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974–978.

22Fazekas G, Fazekas F, Schmidt R, Kapeller P, Offenbacher H, Krejs GJ: Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci 1995;134:83–88.

23Kim CD, Lee HJ, Kim DJ, Kim BS, Shin SK, Do JY, et al: High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis 2007;50:98–107.

24Naganuma T, Takemoto Y, Shoji T, Shima H, Ishimura E, Okamura M, et al: Cerebral white matter hyperintensity predicts cardiovascular events in haemodialysis patients. Nephrology (Carlton) 2013;18:676–681.

25Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A: Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008;39:794–799.

26Bokura H, Kobayashi S, Yamaguchi S, Iijima K, Nagai A, Toyoda G, et al: Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 2006;15:57–63.

27Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM, et al: Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126–1129.

28Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al: Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165–174.

29Viswanathan A, Chabriat H: Cerebral microhemorrhage. Stroke 2006;37:550–555.

30Watanabe A: Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 2007;16:30–33.

31Yokoyama S, Hirano H, Uomizu K, Kajiya Y, Tajitsu K, Kusumoto K: High incidence of microbleeds in hemodialysis patients detected by T2*-weighted gradient-echo magnetic resonance imaging. Neurol Med Chir (Tokyo) 2005;45:556–560; discussion 560.

32Naganuma T, Takemoto Y, Shoji T, Ishimura E, Okamura M, Nakatani T: Cerebral microbleeds predict intracerebral hemorrhage in hemodialysis patients. Stroke 2015;46:2107–2112.

Toshihide Naganuma, MD

Department of Urology

Osaka City University Medical School

1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585 (Japan)

E-Mail spxd48k9@aria.ocn.ne.jp